Literature DB >> 24201312

Integrated analysis of the Wnt responsive proteome in human cells reveals diverse and cell-type specific networks.

J Song1, Z Wang, R M Ewing.   

Abstract

Wnt signalling is a fundamentally important signalling pathway that regulates many aspects of metazoan development and is frequently dysregulated in cancer. Although many of the core components of the Wnt signalling pathway, such as β-catenin, have been extensively studied, the broad systems level responses of the mammalian cell to Wnt signalling are less well understood. In addition, the cell- or tissue-specific protein networks that modulate Wnt signalling in the diverse tissues or developmental stages in which it functions remain to be defined. To address these questions, we undertook a broad survey of the Wnt response in different human cell lines using both interaction and expression proteomics approaches. Our data reveal both similar and divergent responses of pathways and processes in the three cell-lines analyzed as well as a marked attenuation of the response to exogenous Wnt treatment in cells harbouring a stabilizing (activating) mutation of β-catenin. We also identify cell-type specific components of the Wnt signalling network and find that by integrating expression and interaction proteomics data a more complete description of the Wnt interaction network can be achieved. Finally, our results attest to the power of LC-MS/MS to reveal novel cellular responses in even relatively well studied biological pathways such as Wnt signalling.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24201312      PMCID: PMC3909504          DOI: 10.1039/c3mb70417c

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  40 in total

1.  Tissue- and stage-specific modulation of Wingless signaling by the segment polarity gene lines.

Authors:  V Hatini; P Bokor; R Goto-Mandeville; S DiNardo
Journal:  Genes Dev       Date:  2000-06-01       Impact factor: 11.361

2.  A statistical model for identifying proteins by tandem mass spectrometry.

Authors:  Alexey I Nesvizhskii; Andrew Keller; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2003-09-01       Impact factor: 6.986

Review 3.  Convergence of Wnt, beta-catenin, and cadherin pathways.

Authors:  W James Nelson; Roel Nusse
Journal:  Science       Date:  2004-03-05       Impact factor: 47.728

Review 4.  The Wnt signaling pathway in development and disease.

Authors:  Catriona Y Logan; Roel Nusse
Journal:  Annu Rev Cell Dev Biol       Date:  2004       Impact factor: 13.827

Review 5.  Lessons from hereditary colorectal cancer.

Authors:  K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1996-10-18       Impact factor: 41.582

6.  Proteomic analysis identifies that 14-3-3zeta interacts with beta-catenin and facilitates its activation by Akt.

Authors:  Qiang Tian; Megan C Feetham; W Andy Tao; Xi C He; Linheng Li; Ruedi Aebersold; Leroy Hood
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-18       Impact factor: 11.205

7.  Plakoglobin (gamma-catenin) has TCF/LEF family-dependent transcriptional activity in beta-catenin-deficient cell line.

Authors:  Osamu Maeda; Noriyasu Usami; Masashi Kondo; Masahide Takahashi; Hidemi Goto; Kaoru Shimokata; Kazuo Kusugami; Yoshitaka Sekido
Journal:  Oncogene       Date:  2004-01-29       Impact factor: 9.867

8.  Lef-1 and Tcf-3 transcription factors mediate tissue-specific Wnt signaling during Xenopus development.

Authors:  Giulietta Roël; Fiona S Hamilton; Yoony Gent; Andrew A Bain; Olivier Destrée; Stefan Hoppler
Journal:  Curr Biol       Date:  2002-11-19       Impact factor: 10.834

9.  Targeted inactivation of CTNNB1 reveals unexpected effects of beta-catenin mutation.

Authors:  Timothy A Chan; Zhenghe Wang; Long H Dang; Bert Vogelstein; Kenneth W Kinzler
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

10.  BASP1 is a transcriptional cosuppressor for the Wilms' tumor suppressor protein WT1.

Authors:  Brian Carpenter; Kathryn J Hill; Marika Charalambous; Kate J Wagner; Diya Lahiri; Dominic I James; Jens S Andersen; Valérie Schumacher; Brigitte Royer-Pokora; Matthias Mann; Andrew Ward; Stefan G E Roberts
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

View more
  8 in total

1.  β-TrCP1 Is a Vacillatory Regulator of Wnt Signaling.

Authors:  Marcus John Long; Hong-Yu Lin; Saba Parvez; Yi Zhao; Jesse Richard Poganik; Paul Huang; Yimon Aye
Journal:  Cell Chem Biol       Date:  2017-07-20       Impact factor: 8.116

Review 2.  Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review.

Authors:  Miguel Angel Chiurillo
Journal:  World J Exp Med       Date:  2015-05-20

3.  A Protein Interaction between β-Catenin and Dnmt1 Regulates Wnt Signaling and DNA Methylation in Colorectal Cancer Cells.

Authors:  Jing Song; Zhanwen Du; Mate Ravasz; Bohan Dong; Zhenghe Wang; Rob M Ewing
Journal:  Mol Cancer Res       Date:  2015-03-09       Impact factor: 5.852

4.  β-Catenin Knockdown Affects Mitochondrial Biogenesis and Lipid Metabolism in Breast Cancer Cells.

Authors:  Daniele Vergara; Eleonora Stanca; Flora Guerra; Paola Priore; Antonio Gaballo; Julien Franck; Pasquale Simeone; Marco Trerotola; Stefania De Domenico; Isabelle Fournier; Cecilia Bucci; Michel Salzet; Anna M Giudetti; Michele Maffia
Journal:  Front Physiol       Date:  2017-07-27       Impact factor: 4.566

5.  Rewiring of the inferred protein interactome during blood development studied with the tool PPICompare.

Authors:  Thorsten Will; Volkhard Helms
Journal:  BMC Syst Biol       Date:  2017-04-04

6.  Functional high-throughput screen identifies microRNAs that promote butyrate-induced death in colorectal cancer cells.

Authors:  Saira R Ali; Karen J Humphreys; Kaylene J Simpson; Ross A McKinnon; Robyn Meech; Michael Z Michael
Journal:  Mol Ther Nucleic Acids       Date:  2022-08-29       Impact factor: 10.183

Review 7.  Human protein interaction networks across tissues and diseases.

Authors:  Esti Yeger-Lotem; Roded Sharan
Journal:  Front Genet       Date:  2015-08-19       Impact factor: 4.599

8.  ELF3 is an antagonist of oncogenic-signalling-induced expression of EMT-TF ZEB1.

Authors:  D Liu; Y Skomorovska; J Song; E Bowler; R Harris; M Ravasz; S Bai; M Ayati; K Tamai; M Koyuturk; X Yuan; Z Wang; Y Wang; R M Ewing
Journal:  Cancer Biol Ther       Date:  2018-08-27       Impact factor: 4.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.